Key facts
- Second Nature (Clinics/Outpatient Services)’s last known valuation is $46.5M.
- It has raised $29.0M; the latest was Later Stage VC ($540K) in May 2024.
- Notable investors include Plug and Play Tech Center, Innovate UK, 500 Global, Speedinvest, Calm/Storm Ventures — 19 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for Second Nature (Clinics/Outpatient Services)
- ·The full record, as it builds
Funding rounds
No funding rounds for Second Nature (Clinics/Outpatient Services) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Second Nature (Clinics/Outpatient Services)
Operator of a lifestyle improvement platform intended to inspire, educate, and support those at risk of chronic lifestyle diseases. The company offers personalized programs developed by dietitians and psychologists and provides ongoing one-on-one support from a nutritionist that people need to prevent diabetes by using a smart plan, enabling individuals to improve their mood, sleep, and energy levels while losing weight.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2013
- Employees
- 133
- Website
- secondnature.io/
- Ownership
- Privately Held (backing)
Second Nature (Clinics/Outpatient Services) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Second Nature (Clinics/Outpatient Services) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Second Nature (Clinics/Outpatient Services) in its N-PORT filings yet. We sweep new filings monthly.